Lee's Pharm: Lee's acquires global rights to Windtree's Aerosurf aerosolized KL4 surfactant

Windtree Therapeutics said that it has signed a deal with Lee's Pharmaceutical and its subsidiary Zhaoke Pharmaceutical giving Lee's global rights to develop and commercialize Windtree surfactants for any potential indications, including Aerosurf aerosolized KL4 surfactant for the treatment of premature infants with respiratory distress syndrome. According to Windtree, the deal includes milestone payments worth up to [...]